Multiple myeloma and second malignancies.
Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
Monika
M
Engelhardt
Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
Ralph
R
Wäsch
Multiple Myeloma Section, Metabolism Branch, National Cancer Institute, Bethesda, MD.
Ola
O
Landgren
Department of Hematology and Oncology, University of Freiburg Medical Center, Freiburg, Germany.
Martina
M
Kleber
D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000175:diagnosis*; D012042:Registries / Q000706:statistics & numerical data*; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
D013792:Thalidomide; D000077269:Lenalidomide